Welsh, Carson, Anderson & Stowe related stories
All articles and analysis
WCAS taps Taheri as operating partner for healthcare teamWelsh, Carson, Anderson & Stowe has named Dr. Paul Taheri as an operating partner on the healthcare team. Currently, Taheri is CEO of Yale Medicine and a deputy dean for clinical affairs at the Yale School of Medicine.
- PE HUB Wire Highlights, 8.15.19
Ackman's Pershing Square said to buy Berkshire Hathaway stake; Providence prepares launch of first Europe-focused growth fund; Houlihan Lokey expands fintech team
- Menlo Ventures recruits new partner to firm
Menlo Ventures has hired Jean-Paul Sanday as a partner. Previously, he worked at Summit Partners as an inflection-stage investor.
- Welsh Carson, Walgreens invest in Shields Health Solutions
Welsh, Carson, Anderson & Stowe and Walgreens are investing in Shields Health Solutions. Financial terms weren’t announced. Shields is a specialty pharmacy integrator and care provider.
WCAS raises $4.3bnThe New York-based investment firm held a final closing of its thirteenth healthcare technology fund.
- Welsh, Carson, Anderson & Stowe's 13th flagship raises $4.3 bln
Welsh, Carson, Anderson & Stowe said July 30 that its latest flagship closed at its hard cap of $4.3 billion, exceeding its $3.5 billion target. Limited partners' capital totaled $4 billion, while the WCAS GPs and affiliated entities committed approximately $300 million. WCAS XIII LP will invest in healthcare and technology companies, mainly in the U.S.
Connecticut Retirement Plans approves $125m commitmentThe US public pension has backed WCAS' 13th US-focused buyout fund.
Welsh Carson inches closer to $4bn for Fund XIIIThe firm activated fees on the vehicle in January following a $2.8bn first close in August.
The Rainmaker 50Who has the power to turn an investor 'no' into a 'yes'? Who got first-time funds off the ground? Presenting PEI's list of the most influential fundraisers in private equity today.